TABLE 1.
Main clinical characteristics of the study population
| Characteristic | Total no. (%) (n = 302) | No. (%) bacteriologically confirmed TB (n = 48) | No. (%) probable TB (n = 81) | No. (%) non-TB (n = 173) |
|---|---|---|---|---|
| Mean age (interquartile range) | 6.4 (2.1–10.7) | 4.7 (0.8–9.7) | 6.8 (2.8–10.7) | 6.5 (2.1–10.6) |
| Gender | ||||
| Male | 169 (56.0) | 26 (54.2) | 42 (51.9) | 101 (58.4) |
| Female | 133 (44.0) | 22 (45.8) | 39 (48.1) | 72 (41.6) |
| Mycobacterium bovis BCG vaccination | ||||
| Yes | 122 (40.4) | 23 (47.9) | 21 (25.9) | 78 (45.1) |
| No | 95 (31.5) | 17 (35.4) | 38 (46.9) | 40 (23.1) |
| Unclear | 85 (28.1) | 8 (16.7) | 22 (27.2) | 55 (31.8) |
| Tuberculin skin test | ||||
| Positive | 133 (44.0) | 32 (66.7) | 60 (74.1) | 41 (23.7) |
| Negative | 119 (39.4) | 11 (22.9) | 21 (25.9) | 87 (50.3) |
| No data | 50 (16.6) | 5 (10.4) | 0 (0) | 45 (26.0) |
| Interferon γ release assay | ||||
| Positive | 165 (54.6) | 42 (87.5) | 69 (85.2) | 54 (31.2) |
| Negative | 99 (32.8) | 3 (6.3) | 11 (13.6) | 85 (49.1) |
| No data | 38 (12.6) | 3 (6.3) | 1 (1.2) | 34 (19.7) |